Ronette L Kolotkin

Developer of Impact of Weight on Quality of Life assessment tools for adults with obesity (IWQOL-Lite© and IWQOL-Lite-CT©) and adolescents with obesity (IWQOL-Kids©).

Consultant to pharmaceutical companies, universities and other organizations

Clinical trials for pharmacological, surgical and other treatments of obesity and related illnesses
Development and testing of products and materials for persons with obesity
Assessment and interpretation of quality of life data

Current Appointments & Affiliations

Adjunct Professor in the Department of Family Medicine and Community Health · 2025 - Present Family Medicine and Community Health, Diet & Fitness Center, Family Medicine and Community Health

Recent Publications

Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial.

Journal Article Lancet Diabetes Endocrinol · May 2025 BACKGROUND: For individuals with obesity and type 2 diabetes, weight loss improves insulin sensitivity and β-cell function and can induce remission of diabetes. However, the long-term comparative effectiveness of standard gastric bypass and sleeve gastrect ... Full text Link to item Cite

Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials.

Journal Article Diabetes Obes Metab · July 2024 AIMS: To summarize the effects of semaglutide 2.4 mg on weight-related quality of life (WRQOL) and health-related quality of life (HRQOL), focusing on the confirmatory secondary endpoint of physical functioning. MATERIALS AND METHODS: The STEP 1-4 Phase 3a ... Full text Link to item Cite

Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.

Journal Article Clin Obes · August 2023 We assessed the effect of semaglutide 2.4 and 1.7 mg versus placebo on weight-related quality of life (WRQOL) and health-related quality of life (HRQOL) in the STEP 6 trial. Adults from East Asia (body mass index [BMI] ≥27.0 kg/m2 with ≥2 weight-related co ... Full text Link to item Cite

View All Publications

Education, Training & Certifications

University of Minnesota, Twin Cities · 1978 Ph.D.

External Links

Quality of Life Consulting, PLLC